Silk fibroin protein is extruded from insects and worms. It has biocompatible properties with the human body and possesses relatively high tensile strength.
The following pictures below are synthetic silk fibroin protein blood vessels taken from the arteries and veins of a deceased CoVid-19 vaxxinated person by embalmer Richard Heirschman.
Notice that the article suggests that silkworm technology is, “Safe and Effective.”
[2] COVID-19 Vaccination would be more Hazardous than Disease itself in 30 Out of 58 Countries - https://www.scireslit.com/PublicHealth/download.php?file=AJEPH-ID45.pdf
[3] mRNA create Carbon Nanotubes Carbon nanotubes in COVID-19: A critical review and prospects https://www.sciencedirect.com/science/article/pii/S2215038221001849
[4] The FDA and CDC both admit that Carbon Nanotubes are harmful to health and an OSHA violation. https://www.cdc.gov/niosh/docs/2013-145/pdfs/2013-145.pdf
[5] Here the FDA admits CNT (Carbon nanotubes) are hazardous to health and an OSHA violation. (How they defrauded the companies and investors). https://www.fda.gov/files/vaccines,%20blood%20&%20biologics/published/Insight-into-How-Carbon-Nanotubes-Cause-a-Thrombus--Activation-of-Platelets-Through-“Store-Operated”-Calcium-Entry.pdf
[6] Here we have Vanguard’s 89 pages of filed documents showing investors of the hospital and healthcare systems arguing over how much tax payers should pay for their shots they promoted, lied about, and hushed opposition thereof! https://www.sec.gov/divisions/corpfin/cf-noaction/14a-8/2020/trinitypfizer121820-14a8-incoming.pdf
[7] Does Remdesvir Cause Kidney Failure?
In the case of remdesivir causing kidney failure, it's most likely from a build up of an excipient used in Remdesvir (betadex sulfobutyl ether sodium).
FDA Approves Remdesivir in Kidney Patients after Failed Trial
In a move that defies all regulatory convention, the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir) in COVID-19 patients with severe renal impairment, including those on dialysis. With this approval, Veklury is now the first and only approved antiviral COVID-19 treatment that can be used across all stages of renal disease but has no efficacy data to support its administration.
The phase 3 REDPINE trial failed to recruit sufficient subjects to assess efficacy. Instead of properly rejecting the application, the FDA went ahead and approved the drug with insufficient safety and efficacy data. The drug has struggled in recent years as patients commonly decline the antiviral since the November, 2020, WHO warning against inpatient use. Remdesivir can cause both kidney injury and liver damage, thus with no mortality benefit, many believe it should not be used.
The FDA approval action defies logic and will be added to a long list of acts that will be considered malfeasance and will be up for review when the commissioner and agency is finally called to justice.
[8] Excess Deaths from All Causes Above the Five-Year Average
[9] The causes of excess deaths in 2022 has inverted!
Spring 2020:
Acute resp infection 32%
Diabetes 22%
Ischaemic heart disease 14%
Heart Failure 7%
Spring 2022:
Acute resp infection 10%
Diabetes 23%
Ischaemic heart disease 30%
Heart Failure 31%
[10] What Was the Cause For the Increases in Excess Deaths and the Inversion From SARS to Mycorditis?
a
hi